vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $733.7M, roughly 1.3× BRIGHT HORIZONS FAMILY SOLUTIONS INC.). On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 8.8%). BRIGHT HORIZONS FAMILY SOLUTIONS INC. produced more free cash flow last quarter ($258.5M vs $96.9M). Over the past eight quarters, BRIGHT HORIZONS FAMILY SOLUTIONS INC.'s revenue compounded faster (8.5% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.
ATR vs BFAM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $733.7M |
| Net Profit | $74.3M | — |
| Gross Margin | — | 19.3% |
| Operating Margin | 11.0% | 6.2% |
| Net Margin | 7.7% | — |
| Revenue YoY | 13.5% | 8.8% |
| Net Profit YoY | -26.4% | — |
| EPS (diluted) | $1.13 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $733.7M | ||
| Q3 25 | $961.1M | $802.8M | ||
| Q2 25 | $966.0M | $731.6M | ||
| Q1 25 | $887.3M | $665.5M | ||
| Q4 24 | $848.1M | $674.1M | ||
| Q3 24 | $909.3M | $719.1M | ||
| Q2 24 | $910.1M | $670.1M | ||
| Q1 24 | $915.4M | $622.7M |
| Q4 25 | $74.3M | — | ||
| Q3 25 | $127.9M | $78.6M | ||
| Q2 25 | $111.7M | $54.8M | ||
| Q1 25 | $78.8M | $38.0M | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $100.0M | $54.9M | ||
| Q2 24 | $90.5M | $39.2M | ||
| Q1 24 | $83.1M | $17.0M |
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 27.0% | ||
| Q2 25 | — | 25.0% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | 24.2% | ||
| Q1 24 | — | 21.7% |
| Q4 25 | 11.0% | 6.2% | ||
| Q3 25 | 14.2% | 15.1% | ||
| Q2 25 | 14.9% | 11.8% | ||
| Q1 25 | 12.8% | 9.4% | ||
| Q4 24 | 14.2% | 7.2% | ||
| Q3 24 | 15.2% | 12.4% | ||
| Q2 24 | 13.8% | 10.3% | ||
| Q1 24 | 12.2% | 6.4% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 13.3% | 9.8% | ||
| Q2 25 | 11.6% | 7.5% | ||
| Q1 25 | 8.9% | 5.7% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 11.0% | 7.6% | ||
| Q2 24 | 9.9% | 5.8% | ||
| Q1 24 | 9.1% | 2.7% |
| Q4 25 | $1.13 | $0.38 | ||
| Q3 25 | $1.92 | $1.37 | ||
| Q2 25 | $1.67 | $0.95 | ||
| Q1 25 | $1.17 | $0.66 | ||
| Q4 24 | $1.48 | $0.50 | ||
| Q3 24 | $1.48 | $0.94 | ||
| Q2 24 | $1.34 | $0.67 | ||
| Q1 24 | $1.23 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $140.1M |
| Total DebtLower is stronger | $1.1B | $747.6M |
| Stockholders' EquityBook value | $2.7B | $1.3B |
| Total Assets | $5.3B | $3.9B |
| Debt / EquityLower = less leverage | 0.43× | 0.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $140.1M | ||
| Q3 25 | $264.8M | $116.6M | ||
| Q2 25 | $169.8M | $179.2M | ||
| Q1 25 | $136.8M | $112.0M | ||
| Q4 24 | $226.2M | $110.3M | ||
| Q3 24 | $327.9M | $109.9M | ||
| Q2 24 | $223.9M | $140.2M | ||
| Q1 24 | $201.1M | $63.7M |
| Q4 25 | $1.1B | $747.6M | ||
| Q3 25 | $546.0M | $747.5M | ||
| Q2 25 | $535.1M | $797.0M | ||
| Q1 25 | $561.2M | $872.7M | ||
| Q4 24 | $688.1M | $918.4M | ||
| Q3 24 | $822.7M | $925.7M | ||
| Q2 24 | $681.5M | $931.9M | ||
| Q1 24 | $680.4M | $938.1M |
| Q4 25 | $2.7B | $1.3B | ||
| Q3 25 | $2.8B | $1.4B | ||
| Q2 25 | $2.7B | $1.4B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.5B | $1.3B | ||
| Q3 24 | $2.5B | $1.4B | ||
| Q2 24 | $2.4B | $1.3B | ||
| Q1 24 | $2.3B | $1.2B |
| Q4 25 | $5.3B | $3.9B | ||
| Q3 25 | $5.1B | $3.9B | ||
| Q2 25 | $4.9B | $3.9B | ||
| Q1 25 | $4.5B | $3.8B | ||
| Q4 24 | $4.4B | $3.9B | ||
| Q3 24 | $4.6B | $3.9B | ||
| Q2 24 | $4.5B | $3.8B | ||
| Q1 24 | $4.4B | $3.8B |
| Q4 25 | 0.43× | 0.56× | ||
| Q3 25 | 0.20× | 0.52× | ||
| Q2 25 | 0.20× | 0.57× | ||
| Q1 25 | 0.22× | 0.66× | ||
| Q4 24 | 0.28× | 0.72× | ||
| Q3 24 | 0.32× | 0.66× | ||
| Q2 24 | 0.28× | 0.73× | ||
| Q1 24 | 0.29× | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $350.7M |
| Free Cash FlowOCF − Capex | $96.9M | $258.5M |
| FCF MarginFCF / Revenue | 10.1% | 35.2% |
| Capex IntensityCapex / Revenue | 9.0% | 12.6% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $402.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $350.7M | ||
| Q3 25 | $177.6M | $-17.6M | ||
| Q2 25 | $126.0M | $134.2M | ||
| Q1 25 | $82.7M | $86.2M | ||
| Q4 24 | $178.2M | $337.5M | ||
| Q3 24 | $229.3M | $-8.9M | ||
| Q2 24 | $143.6M | $109.4M | ||
| Q1 24 | $92.3M | $116.3M |
| Q4 25 | $96.9M | $258.5M | ||
| Q3 25 | $114.3M | $-42.4M | ||
| Q2 25 | $62.5M | $115.4M | ||
| Q1 25 | $25.9M | $70.9M | ||
| Q4 24 | $112.2M | $240.2M | ||
| Q3 24 | $162.7M | $-32.2M | ||
| Q2 24 | $75.4M | $86.8M | ||
| Q1 24 | $16.7M | $96.9M |
| Q4 25 | 10.1% | 35.2% | ||
| Q3 25 | 11.9% | -5.3% | ||
| Q2 25 | 6.5% | 15.8% | ||
| Q1 25 | 2.9% | 10.7% | ||
| Q4 24 | 13.2% | 35.6% | ||
| Q3 24 | 17.9% | -4.5% | ||
| Q2 24 | 8.3% | 13.0% | ||
| Q1 24 | 1.8% | 15.6% |
| Q4 25 | 9.0% | 12.6% | ||
| Q3 25 | 6.6% | 3.1% | ||
| Q2 25 | 6.6% | 2.6% | ||
| Q1 25 | 6.4% | 2.3% | ||
| Q4 24 | 7.8% | 14.4% | ||
| Q3 24 | 7.3% | 3.2% | ||
| Q2 24 | 7.5% | 3.4% | ||
| Q1 24 | 8.3% | 3.1% |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | -0.22× | ||
| Q2 25 | 1.13× | 2.45× | ||
| Q1 25 | 1.05× | 2.26× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | -0.16× | ||
| Q2 24 | 1.59× | 2.79× | ||
| Q1 24 | 1.11× | 6.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
BFAM
Segment breakdown not available.
